Jazz Pharmaceuticals reports FDA acceptance and Priority Review of sBLA for Ziihera (zanidatamab-hrii) combinations in first-line HER2+ locally advanced or metastatic GEA

Novartis secures European approval for remibrutinib in chronic spontaneous urticaria

GSK secures US and EU fast-track designations for efimosfermin in MASH

Veradermics reports positive Phase 2/3 results for oral VDPHL01 in pattern hair loss treatment

Cantargia reports early remission data from nadunolimab trial in MDS and AML

AOTI reports strong real-world outcomes for TWO2 wound therapy

WuXi Biologics announces structural completion and key equipment arrival at Chengdu microbial manufacturing site

HanchorBio chooses Bloomberg to enhance strategic intelligence across drug development and global biopharma

Ascletis completes enrolment for US Phase II study of ASC30 in diabetes

Servier completes Day One Biopharmaceuticals acquisition

Cipla's AB-rated Ventolin HFA generic receives US FDA approval

Apotex and Cumberland Pharmaceuticals to integrate their US branded businesses

Orion Pharma launches Phase 1b/2 TEADCO trial of ODM-212 in advanced solid tumours

FDA expands Sanofi and Regeneron's Dupixent approval to younger children with chronic spontaneous urticaria

WuXi Biologics gains MFDS approval for three Wuxi manufacturing sites